Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN
Pancreatic ductal adenocarcinoma (PDAC) may derive from an intraductal papillary mucinous neoplasm (IPMN) of the pancreas or may develop in the pancreatic duct apart from IPMN. The purpose of this study was to define the clinicopathological features of these 2 entities and compare them with those of...
Gespeichert in:
| Veröffentlicht in: | Pancreas 2011-05, Vol.40 (4), p.571-580 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 580 |
|---|---|
| container_issue | 4 |
| container_start_page | 571 |
| container_title | Pancreas |
| container_volume | 40 |
| creator | Yamaguchi, Koji Kanemitsu, Shuichi Hatori, Takashi Maguchi, Hiroyuki Shimizu, Yasuhiro Tada, Minoru Nakagohri, Toshio Hanada, Keiji Osanai, Manabu Noda, Yutaka Nakaizumi, Akihiko Furukawa, Toru Ban, Shinichi Nobukawa, Bunsei Kato, Yo Tanaka, Masao |
| description | Pancreatic ductal adenocarcinoma (PDAC) may derive from an intraductal papillary mucinous neoplasm (IPMN) of the pancreas or may develop in the pancreatic duct apart from IPMN. The purpose of this study was to define the clinicopathological features of these 2 entities and compare them with those of ordinary PDAC.
Of 765 patients who had surgical resection for IPMN, 122 were diagnosed as having PDAC derived from IPMN and 31 with PDAC concomitant with IPMN. In addition, 7605 patients with PDAC who were registered in the Japan Pancreas Society pancreatic cancer registry were compared with the above patients.
Pancreatic ductal adenocarcinomas derived from IPMN and concomitant with IPMN were significantly smaller, less invasive, and less extensive than ordinary PDAC. The median survival of patients with the 2 conditions was significantly longer than for those with ordinary PDAC when compared overall or when limited to TS2 (2.0 cm < tumor size ≤ 4.0 cm) or TS3 (4.0 cm < tumor size ≤ 6.0 cm) cases.
These findings suggest that PDAC concomitant with IPMN and PDAC derived from IPMN may have more favorable biological behaviors or be diagnosed earlier than ordinary PDAC. |
| doi_str_mv | 10.1097/MPA.0b013e318215010c |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_868999894</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>868999894</sourcerecordid><originalsourceid>FETCH-LOGICAL-c306t-644a29a114cd484b9fef20496a9f17b9654e39011c9ac9c89ab91d21ec416e5a3</originalsourceid><addsrcrecordid>eNqFkD1PwzAURS0EoqXwDxDKxpTiFzuJ31hVfFRqoQPM0YvtiKAkLnYC4t9TaGFgYbrLPfdKh7Fz4FPgmF-t1rMpLzkIK0AlkHLg-oCNIRVZLFWiDtmYK5XGAvJ8xE5CeOEccpHiMRslIBETSMasXVOnvaW-1pEZdE9NRMZ2TpPXdedaioz19Zs1UeVdGy3Wq_uIOhNt_sO067Rr6566Pnqv--dv9JQdVdQEe7bPCXu6uX6c38XLh9vFfLaMteBZH2dSUoIEILWRSpZY2SrhEjPCCvISs1RagRxAI2nUCqlEMAlYLSGzKYkJu9ztbrx7HWzoi7YO2jYNddYNoVCZQkSFctuUu6b2LgRvq2Lj65b8RwG8-PJcbD0Xfz1vsYv9wVC21vxCP2LFJ2KFeqg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>868999894</pqid></control><display><type>article</type><title>Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Yamaguchi, Koji ; Kanemitsu, Shuichi ; Hatori, Takashi ; Maguchi, Hiroyuki ; Shimizu, Yasuhiro ; Tada, Minoru ; Nakagohri, Toshio ; Hanada, Keiji ; Osanai, Manabu ; Noda, Yutaka ; Nakaizumi, Akihiko ; Furukawa, Toru ; Ban, Shinichi ; Nobukawa, Bunsei ; Kato, Yo ; Tanaka, Masao</creator><creatorcontrib>Yamaguchi, Koji ; Kanemitsu, Shuichi ; Hatori, Takashi ; Maguchi, Hiroyuki ; Shimizu, Yasuhiro ; Tada, Minoru ; Nakagohri, Toshio ; Hanada, Keiji ; Osanai, Manabu ; Noda, Yutaka ; Nakaizumi, Akihiko ; Furukawa, Toru ; Ban, Shinichi ; Nobukawa, Bunsei ; Kato, Yo ; Tanaka, Masao</creatorcontrib><description>Pancreatic ductal adenocarcinoma (PDAC) may derive from an intraductal papillary mucinous neoplasm (IPMN) of the pancreas or may develop in the pancreatic duct apart from IPMN. The purpose of this study was to define the clinicopathological features of these 2 entities and compare them with those of ordinary PDAC.
Of 765 patients who had surgical resection for IPMN, 122 were diagnosed as having PDAC derived from IPMN and 31 with PDAC concomitant with IPMN. In addition, 7605 patients with PDAC who were registered in the Japan Pancreas Society pancreatic cancer registry were compared with the above patients.
Pancreatic ductal adenocarcinomas derived from IPMN and concomitant with IPMN were significantly smaller, less invasive, and less extensive than ordinary PDAC. The median survival of patients with the 2 conditions was significantly longer than for those with ordinary PDAC when compared overall or when limited to TS2 (2.0 cm < tumor size ≤ 4.0 cm) or TS3 (4.0 cm < tumor size ≤ 6.0 cm) cases.
These findings suggest that PDAC concomitant with IPMN and PDAC derived from IPMN may have more favorable biological behaviors or be diagnosed earlier than ordinary PDAC.</description><identifier>ISSN: 0885-3177</identifier><identifier>EISSN: 1536-4828</identifier><identifier>DOI: 10.1097/MPA.0b013e318215010c</identifier><identifier>PMID: 21499212</identifier><language>eng</language><publisher>United States</publisher><subject>Adenocarcinoma - pathology ; Adenocarcinoma, Mucinous - pathology ; Aged ; Carcinoma, Pancreatic Ductal - pathology ; Carcinoma, Papillary - pathology ; Female ; Humans ; Japan ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Staging ; Neoplasms, Second Primary - pathology ; Pancreas - pathology ; Pancreatic Neoplasms - pathology ; Registries - statistics & numerical data ; Survival Analysis</subject><ispartof>Pancreas, 2011-05, Vol.40 (4), p.571-580</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c306t-644a29a114cd484b9fef20496a9f17b9654e39011c9ac9c89ab91d21ec416e5a3</citedby><cites>FETCH-LOGICAL-c306t-644a29a114cd484b9fef20496a9f17b9654e39011c9ac9c89ab91d21ec416e5a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21499212$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamaguchi, Koji</creatorcontrib><creatorcontrib>Kanemitsu, Shuichi</creatorcontrib><creatorcontrib>Hatori, Takashi</creatorcontrib><creatorcontrib>Maguchi, Hiroyuki</creatorcontrib><creatorcontrib>Shimizu, Yasuhiro</creatorcontrib><creatorcontrib>Tada, Minoru</creatorcontrib><creatorcontrib>Nakagohri, Toshio</creatorcontrib><creatorcontrib>Hanada, Keiji</creatorcontrib><creatorcontrib>Osanai, Manabu</creatorcontrib><creatorcontrib>Noda, Yutaka</creatorcontrib><creatorcontrib>Nakaizumi, Akihiko</creatorcontrib><creatorcontrib>Furukawa, Toru</creatorcontrib><creatorcontrib>Ban, Shinichi</creatorcontrib><creatorcontrib>Nobukawa, Bunsei</creatorcontrib><creatorcontrib>Kato, Yo</creatorcontrib><creatorcontrib>Tanaka, Masao</creatorcontrib><title>Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN</title><title>Pancreas</title><addtitle>Pancreas</addtitle><description>Pancreatic ductal adenocarcinoma (PDAC) may derive from an intraductal papillary mucinous neoplasm (IPMN) of the pancreas or may develop in the pancreatic duct apart from IPMN. The purpose of this study was to define the clinicopathological features of these 2 entities and compare them with those of ordinary PDAC.
Of 765 patients who had surgical resection for IPMN, 122 were diagnosed as having PDAC derived from IPMN and 31 with PDAC concomitant with IPMN. In addition, 7605 patients with PDAC who were registered in the Japan Pancreas Society pancreatic cancer registry were compared with the above patients.
Pancreatic ductal adenocarcinomas derived from IPMN and concomitant with IPMN were significantly smaller, less invasive, and less extensive than ordinary PDAC. The median survival of patients with the 2 conditions was significantly longer than for those with ordinary PDAC when compared overall or when limited to TS2 (2.0 cm < tumor size ≤ 4.0 cm) or TS3 (4.0 cm < tumor size ≤ 6.0 cm) cases.
These findings suggest that PDAC concomitant with IPMN and PDAC derived from IPMN may have more favorable biological behaviors or be diagnosed earlier than ordinary PDAC.</description><subject>Adenocarcinoma - pathology</subject><subject>Adenocarcinoma, Mucinous - pathology</subject><subject>Aged</subject><subject>Carcinoma, Pancreatic Ductal - pathology</subject><subject>Carcinoma, Papillary - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Japan</subject><subject>Lymphatic Metastasis</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Neoplasms, Second Primary - pathology</subject><subject>Pancreas - pathology</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Registries - statistics & numerical data</subject><subject>Survival Analysis</subject><issn>0885-3177</issn><issn>1536-4828</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkD1PwzAURS0EoqXwDxDKxpTiFzuJ31hVfFRqoQPM0YvtiKAkLnYC4t9TaGFgYbrLPfdKh7Fz4FPgmF-t1rMpLzkIK0AlkHLg-oCNIRVZLFWiDtmYK5XGAvJ8xE5CeOEccpHiMRslIBETSMasXVOnvaW-1pEZdE9NRMZ2TpPXdedaioz19Zs1UeVdGy3Wq_uIOhNt_sO067Rr6566Pnqv--dv9JQdVdQEe7bPCXu6uX6c38XLh9vFfLaMteBZH2dSUoIEILWRSpZY2SrhEjPCCvISs1RagRxAI2nUCqlEMAlYLSGzKYkJu9ztbrx7HWzoi7YO2jYNddYNoVCZQkSFctuUu6b2LgRvq2Lj65b8RwG8-PJcbD0Xfz1vsYv9wVC21vxCP2LFJ2KFeqg</recordid><startdate>201105</startdate><enddate>201105</enddate><creator>Yamaguchi, Koji</creator><creator>Kanemitsu, Shuichi</creator><creator>Hatori, Takashi</creator><creator>Maguchi, Hiroyuki</creator><creator>Shimizu, Yasuhiro</creator><creator>Tada, Minoru</creator><creator>Nakagohri, Toshio</creator><creator>Hanada, Keiji</creator><creator>Osanai, Manabu</creator><creator>Noda, Yutaka</creator><creator>Nakaizumi, Akihiko</creator><creator>Furukawa, Toru</creator><creator>Ban, Shinichi</creator><creator>Nobukawa, Bunsei</creator><creator>Kato, Yo</creator><creator>Tanaka, Masao</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201105</creationdate><title>Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN</title><author>Yamaguchi, Koji ; Kanemitsu, Shuichi ; Hatori, Takashi ; Maguchi, Hiroyuki ; Shimizu, Yasuhiro ; Tada, Minoru ; Nakagohri, Toshio ; Hanada, Keiji ; Osanai, Manabu ; Noda, Yutaka ; Nakaizumi, Akihiko ; Furukawa, Toru ; Ban, Shinichi ; Nobukawa, Bunsei ; Kato, Yo ; Tanaka, Masao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c306t-644a29a114cd484b9fef20496a9f17b9654e39011c9ac9c89ab91d21ec416e5a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adenocarcinoma - pathology</topic><topic>Adenocarcinoma, Mucinous - pathology</topic><topic>Aged</topic><topic>Carcinoma, Pancreatic Ductal - pathology</topic><topic>Carcinoma, Papillary - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Japan</topic><topic>Lymphatic Metastasis</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Neoplasms, Second Primary - pathology</topic><topic>Pancreas - pathology</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Registries - statistics & numerical data</topic><topic>Survival Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamaguchi, Koji</creatorcontrib><creatorcontrib>Kanemitsu, Shuichi</creatorcontrib><creatorcontrib>Hatori, Takashi</creatorcontrib><creatorcontrib>Maguchi, Hiroyuki</creatorcontrib><creatorcontrib>Shimizu, Yasuhiro</creatorcontrib><creatorcontrib>Tada, Minoru</creatorcontrib><creatorcontrib>Nakagohri, Toshio</creatorcontrib><creatorcontrib>Hanada, Keiji</creatorcontrib><creatorcontrib>Osanai, Manabu</creatorcontrib><creatorcontrib>Noda, Yutaka</creatorcontrib><creatorcontrib>Nakaizumi, Akihiko</creatorcontrib><creatorcontrib>Furukawa, Toru</creatorcontrib><creatorcontrib>Ban, Shinichi</creatorcontrib><creatorcontrib>Nobukawa, Bunsei</creatorcontrib><creatorcontrib>Kato, Yo</creatorcontrib><creatorcontrib>Tanaka, Masao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pancreas</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamaguchi, Koji</au><au>Kanemitsu, Shuichi</au><au>Hatori, Takashi</au><au>Maguchi, Hiroyuki</au><au>Shimizu, Yasuhiro</au><au>Tada, Minoru</au><au>Nakagohri, Toshio</au><au>Hanada, Keiji</au><au>Osanai, Manabu</au><au>Noda, Yutaka</au><au>Nakaizumi, Akihiko</au><au>Furukawa, Toru</au><au>Ban, Shinichi</au><au>Nobukawa, Bunsei</au><au>Kato, Yo</au><au>Tanaka, Masao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN</atitle><jtitle>Pancreas</jtitle><addtitle>Pancreas</addtitle><date>2011-05</date><risdate>2011</risdate><volume>40</volume><issue>4</issue><spage>571</spage><epage>580</epage><pages>571-580</pages><issn>0885-3177</issn><eissn>1536-4828</eissn><abstract>Pancreatic ductal adenocarcinoma (PDAC) may derive from an intraductal papillary mucinous neoplasm (IPMN) of the pancreas or may develop in the pancreatic duct apart from IPMN. The purpose of this study was to define the clinicopathological features of these 2 entities and compare them with those of ordinary PDAC.
Of 765 patients who had surgical resection for IPMN, 122 were diagnosed as having PDAC derived from IPMN and 31 with PDAC concomitant with IPMN. In addition, 7605 patients with PDAC who were registered in the Japan Pancreas Society pancreatic cancer registry were compared with the above patients.
Pancreatic ductal adenocarcinomas derived from IPMN and concomitant with IPMN were significantly smaller, less invasive, and less extensive than ordinary PDAC. The median survival of patients with the 2 conditions was significantly longer than for those with ordinary PDAC when compared overall or when limited to TS2 (2.0 cm < tumor size ≤ 4.0 cm) or TS3 (4.0 cm < tumor size ≤ 6.0 cm) cases.
These findings suggest that PDAC concomitant with IPMN and PDAC derived from IPMN may have more favorable biological behaviors or be diagnosed earlier than ordinary PDAC.</abstract><cop>United States</cop><pmid>21499212</pmid><doi>10.1097/MPA.0b013e318215010c</doi><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0885-3177 |
| ispartof | Pancreas, 2011-05, Vol.40 (4), p.571-580 |
| issn | 0885-3177 1536-4828 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_868999894 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Adenocarcinoma - pathology Adenocarcinoma, Mucinous - pathology Aged Carcinoma, Pancreatic Ductal - pathology Carcinoma, Papillary - pathology Female Humans Japan Lymphatic Metastasis Male Middle Aged Neoplasm Staging Neoplasms, Second Primary - pathology Pancreas - pathology Pancreatic Neoplasms - pathology Registries - statistics & numerical data Survival Analysis |
| title | Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T13%3A47%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pancreatic%20ductal%20adenocarcinoma%20derived%20from%20IPMN%20and%20pancreatic%20ductal%20adenocarcinoma%20concomitant%20with%20IPMN&rft.jtitle=Pancreas&rft.au=Yamaguchi,%20Koji&rft.date=2011-05&rft.volume=40&rft.issue=4&rft.spage=571&rft.epage=580&rft.pages=571-580&rft.issn=0885-3177&rft.eissn=1536-4828&rft_id=info:doi/10.1097/MPA.0b013e318215010c&rft_dat=%3Cproquest_cross%3E868999894%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=868999894&rft_id=info:pmid/21499212&rfr_iscdi=true |